Emerging Paradigms In Redox Regulation: The Role Of Selenoproteins In Normal And Malignant Hematopoiesis

Aging Pathway
Therapeutic
Selenoproteins, which are crucial antioxidant enzymes, play a vital role in maintaining the delicate balance of cellular processes in blood-forming stem cells, and their deficiency can lead to aging-related decline in blood production and increased susceptibility to a specific type of cell death.
Author

Gemini

Published

December 18, 2025

Our bodies rely on a delicate balance of chemical reactions, known as redox balance, to keep our cells healthy and functioning. When this balance is disrupted, it can lead to various problems, including those affecting our blood-forming system. Recent research sheds light on the critical role of a special group of proteins called selenoproteins in maintaining this balance, particularly within the cells that produce all our blood components, known as hematopoietic stem cells (HSCs).

Selenoproteins are essential antioxidant enzymes, meaning they help protect our cells from damage caused by harmful reactive molecules. This study found that when the production of these selenoproteins is disrupted, it throws the redox balance out of whack. This imbalance leads to an accumulation of damaged fats in cells, a process called lipid peroxidation, and can trigger a specific type of iron-dependent cell death known as ferroptosis.

The consequences of this disruption are significant for our blood system. The research showed that a lack of selenoproteins impairs the ability of HSCs to renew themselves and hinders the proper development of B-cells, a crucial type of immune cell. These effects closely mimic the changes observed in the blood-forming system as we age. Interestingly, the study also suggested that certain interventions, like the use of ferroptosis inhibitors such as vitamin E, could potentially help mitigate some of these negative effects, offering a glimpse into future therapeutic strategies for age-related blood disorders.


Source: link to paper